186 related articles for article (PubMed ID: 23566573)
1. Prognostication in cancer of unknown primary (CUP): development of a prognostic algorithm in 311 cases and review of the literature.
Petrakis D; Pentheroudakis G; Voulgaris E; Pavlidis N
Cancer Treat Rev; 2013 Nov; 39(7):701-8. PubMed ID: 23566573
[TBL] [Abstract][Full Text] [Related]
2. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
Trivanović D; Petkovic M; Stimac D
Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
[TBL] [Abstract][Full Text] [Related]
4. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
[TBL] [Abstract][Full Text] [Related]
5. Single-center management of 136 patients with cancer of unknown primary site (CUP syndrome) over a period of 10 years.
Thöm I; Rogers C; Andritzky B; Witzel I; Schuch G; Hossfeld DK; Bokemeyer C; Laack E
Onkologie; 2009 Dec; 32(12):741-6. PubMed ID: 20016235
[TBL] [Abstract][Full Text] [Related]
6. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Pentheroudakis G; Briasoulis E; Kalofonos HP; Fountzilas G; Economopoulos T; Samelis G; Koutras A; Karina M; Xiros N; Samantas E; Bamias A; Pavlidis N;
Acta Oncol; 2008; 47(6):1148-55. PubMed ID: 18607872
[TBL] [Abstract][Full Text] [Related]
8. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
Shaw PH; Adams R; Jordan C; Crosby TD
Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostics and therapy for neuroendocrine neoplasia of an unknown primary - a plea for open exploration].
Begum N; Hubold C; Buchmann I; Thorns C; Bouchard R; Lubienski A; Schlöricke E; Zimmermann M; Lehnert H; Bruch HP; Bürk CG
Zentralbl Chir; 2014 Jun; 139(3):284-91. PubMed ID: 23508839
[TBL] [Abstract][Full Text] [Related]
10. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.
Ponce Lorenzo J; Segura Huerta A; Díaz Beveridge R; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Richart Aznar P; de la Cueva Sapiña H; Montalar Salcedo J
Clin Transl Oncol; 2007 Jul; 9(7):452-8. PubMed ID: 17652059
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognosis for carcinoma of unknown origin in elderly patients.
Lu HJ; Chen KW; Tzeng CH; Liu JH; Chiou TJ; Yen CC; Chao TC; Teng HW; Chen MH; Liu CY; Wang WS; Chang PM; Yang MH
Oncology; 2012; 83(1):24-30. PubMed ID: 22722484
[TBL] [Abstract][Full Text] [Related]
14. Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007.
Randén M; Rutqvist LE; Johansson H
Acta Oncol; 2009; 48(6):915-20. PubMed ID: 19363713
[TBL] [Abstract][Full Text] [Related]
15. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
16. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma.
Hess KR; Abbruzzese MC; Lenzi R; Raber MN; Abbruzzese JL
Clin Cancer Res; 1999 Nov; 5(11):3403-10. PubMed ID: 10589751
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
19. [Classification and regression tree analysis of 154 patients with cancer of unknown primary].
Wang ZP; Liu YT; Yang J
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):690-3. PubMed ID: 21122385
[TBL] [Abstract][Full Text] [Related]
20. Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy.
Kodaira M; Takahashi S; Yamada S; Ueda K; Mishima Y; Takeuchi K; Yamamoto N; Ishikawa Y; Yokoyama M; Saotome T; Terui Y; Hatake K
Ann Oncol; 2010 Jun; 21(6):1163-1167. PubMed ID: 20019088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]